Image

Registry of Asthma Characterization and Recruitment 3 (RACR3)

Recruiting
years of age
Both
Phase N/A

Powered by AI

Overview

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

Description

Protocol CAUSE-02 RACR3 is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies. Approximately 1,500 participants - of all ages, living in selected Office of Management and Budget (OMB) defined Metropolitan Statistical Areas (MSAs) will be enrolled in the registry.

The registry database will be generated with data gathered at a single core visit, followed by optional additional visits. The registry will include assessments of various asthma and allergy characteristics to achieve a more flexible, efficient, selective, and inclusive approach to participant recruitment while still following national guidelines to foster participant safety. CAUSE investigators may invite children or adults without asthma or atopic diseases to participate in the registry as "healthy" controls; for validation of laboratory tests, study monitoring equipment, and/or procedures; or for site procedure training of study personnel for certification and quality assurance.

Participants may opt to withdraw their information or discontinue from the registry at any time, in person, by telephone, or in writing.

Eligibility

Inclusion Criteria:

  1. Participant is either:
    1. At least 18 years old, willing and able to provide informed consent at the time of enrollment
    2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
  2. Participant has a primary place of residence within the Office of Management and

    Budget (OMB)-defined Metropolitan Statistical Area (MSA)

Exclusion Criteria:

  1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
  2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up
  3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study
        Participants who are pregnant or lactating will not be excluded or discontinued from the
        study, but will not undergo any procedures that are prohibited during pregnancy per the
        Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and
        Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry)
        during the pregnancy.
        Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.

Study details

Asthma

NCT05272241

National Institute of Allergy and Infectious Diseases (NIAID)

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.